Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
"2024 Calibrate Results Report." Calibrate
GLP-1 RAs are recommended as the first injectable agent (over insulin) in most patients with T2D when the glucose-lowering efficacy of an injectable agent is desired
Refer to the Usage & Handling section above for product-specific guidance
Long-term weight management
Common side effects, such as mild nausea or gastrointestinal discomfort, may occur initially but typically lessen as the body adjusts to the treatment
Arrhythmias and Heart Conditions Heart palpitations, those unsettling moments when your heart seems to flutter, skip a beat, or race, can be triggered by a variety of factors
US$ 28.57
US$ 20.77
US$ 22.26
US$ 24.54
US$ 21.62
